LATAM Sales Director - Diagnostics & Theranostics Growth

Curium Pharma; México; On-site; MXN 3,063,000 - 4,764,000; Full time

Job summary

Curium Pharma, the world’s leading nuclear medicine company, seeks a Sales Director LATAM North to drive commercial growth across Mexico, Colombia and Central America. You will lead distributor networks, manage key accounts and deliver revenue targets for Curium’s diagnostic and therapeutic radiopharmaceutical portfolio.

The role combines leadership, market development and operations: setting local go-to-market, enabling market access, coordinating with hospitals and oncology stakeholders, and

Qualifications

• 10-15 years of experience in pharmaceutical sales managing large portfolios in diagnostic and/or therapy.
• Solid experience with hospitals and understanding of supply chain processes.
• Deep knowledge of LATAM markets, especially Mexico, Colombia and Central America.
• Experience in developing emerging healthcare markets and distributor-driven environments.
• Strong LATAM network with top KOLs; ability to foster cross-functional collaboration.

Responsibilities

• Achieve annual sales and revenue objectives across LATAM North.
• Drive sales execution with distributors, partners and direct customers.
• Negotiate commercial agreements aligned with Curium pricing and profitability.
• Develop and implement commercial action plans to grow existing accounts and enter new markets.
• Restore growth in Mexico and accelerate market development in Colombia; expand in Central America.

Skills

Distributor management

Sales leadership

Strategic thinking

Stakeholder engagement

Fluent English

Fluent Spanish

Market development

Negotiation

Cross-functional collaboration

Job description

Curium Pharma, the world’s leading nuclear medicine company, seeks a Sales Director LATAM North to drive commercial growth across Mexico, Colombia and Central America. You will lead distributor networks, manage key accounts and deliver revenue targets for Curium’s diagnostic and therapeutic radiopharmaceutical portfolio.

The role combines leadership, market development and operations: setting local go-to-market, enabling market access, coordinating with hospitals and oncology stakeholders, and